401k Plan data: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN plan

AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 401k Plan overview

Plan Name	AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN
Plan identification number	003

AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 403(b)(1) arrangement - See Limited Pension Plan Reporting instructions for Code section 403(b)(1) arrangements for certain exempt organizations.
Code section 403(b)(7) accounts - See Limited Pension Plan Reporting instructions for Code section 403(b)(7) custodial accounts for regulated investment company stock for certain exempt organizations.
Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.

401k Sponsoring company profile

AMERICAN SOCIETY FOR CLINICAL PATHOLOGY has sponsored the creation of one or more 401k plans.

Company Name: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY

Employer identification number (EIN): 362406080

NAIC Classification: 813000
NAIC Description: Religious, Grantmaking, Civic, Professional, and Similar Organizations

Form 5500 Filing Information

Submission information for form 5500 for 401k plan AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
003 2022-01-01
003 2021-01-01
003 2020-01-01
003 2019-01-01
003 2018-01-01
003 2017-01-01 LISA SIMMONS
003 2016-01-01 LISA SIMMONS
003 2015-01-01 LISA SIMMONS
003 2014-01-01 LISA SIMMONS
003 2013-01-01 JEAN MARIE DILLON
003 2012-01-01 JEAN MARIE DILLON
003 2011-01-01 JEAN MARIE MARDEN JEAN MARIE MARDEN 2012-07-25
003 2009-01-01 JEAN MARIE MARDEN JEAN MARIE MARDEN 2010-10-13
003 2008-01-01 JEAN MARIE MARDEN JEAN MARIE MARDEN 2010-10-13
003 2007-01-01 JEAN MARIE MARDEN JEAN MARIE MARDEN 2010-10-13
003 2006-01-01 JEAN MARIE MARDEN JEAN MARIE MARDEN 2010-10-13
003 2005-01-01 JEAN MARIE MARDEN JEAN MARIE MARDEN 2010-10-13

Plan id#	Filing Submission Date	Name of Administrator	Name of Company Sponsor	Date Sponsor Signed
003	2022-01-01
003	2021-01-01
003	2020-01-01
003	2019-01-01
003	2018-01-01
003	2017-01-01	LISA SIMMONS
003	2016-01-01	LISA SIMMONS
003	2015-01-01	LISA SIMMONS
003	2014-01-01	LISA SIMMONS
003	2013-01-01	JEAN MARIE DILLON
003	2012-01-01	JEAN MARIE DILLON
003	2011-01-01	JEAN MARIE MARDEN	JEAN MARIE MARDEN	2012-07-25
003	2009-01-01	JEAN MARIE MARDEN	JEAN MARIE MARDEN	2010-10-13
003	2008-01-01	JEAN MARIE MARDEN	JEAN MARIE MARDEN	2010-10-13
003	2007-01-01	JEAN MARIE MARDEN	JEAN MARIE MARDEN	2010-10-13
003	2006-01-01	JEAN MARIE MARDEN	JEAN MARIE MARDEN	2010-10-13
003	2005-01-01	JEAN MARIE MARDEN	JEAN MARIE MARDEN	2010-10-13

Plan Statistics for AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN

401k plan membership statisitcs for AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN

Measure Date Value
2022: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2022 401k membership
Total participants, beginning-of-year 2022-01-01 198
Total number of active participants reported on line 7a of the Form 5500 2022-01-01 103
Number of retired or separated participants receiving benefits 2022-01-01 0
Number of other retired or separated participants entitled to future benefits 2022-01-01 93
Total of all active and inactive participants 2022-01-01 196
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2022-01-01 0
Total participants 2022-01-01 196
Number of participants with account balances 2022-01-01 187
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2022-01-01 0
2021: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2021 401k membership
Total participants, beginning-of-year 2021-01-01 196
Total number of active participants reported on line 7a of the Form 5500 2021-01-01 106
Number of retired or separated participants receiving benefits 2021-01-01 0
Number of other retired or separated participants entitled to future benefits 2021-01-01 92
Total of all active and inactive participants 2021-01-01 198
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2021-01-01 0
Total participants 2021-01-01 198
Number of participants with account balances 2021-01-01 190
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2021-01-01 0
2020: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2020 401k membership
Total participants, beginning-of-year 2020-01-01 202
Total number of active participants reported on line 7a of the Form 5500 2020-01-01 102
Number of retired or separated participants receiving benefits 2020-01-01 0
Number of other retired or separated participants entitled to future benefits 2020-01-01 94
Total of all active and inactive participants 2020-01-01 196
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2020-01-01 0
Total participants 2020-01-01 196
Number of participants with account balances 2020-01-01 188
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2020-01-01 0
2019: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2019 401k membership
Total participants, beginning-of-year 2019-01-01 192
Total number of active participants reported on line 7a of the Form 5500 2019-01-01 107
Number of retired or separated participants receiving benefits 2019-01-01 0
Number of other retired or separated participants entitled to future benefits 2019-01-01 96
Total of all active and inactive participants 2019-01-01 203
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2019-01-01 0
Total participants 2019-01-01 203
Number of participants with account balances 2019-01-01 191
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2019-01-01 0
2018: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2018 401k membership
Total participants, beginning-of-year 2018-01-01 192
Total number of active participants reported on line 7a of the Form 5500 2018-01-01 108
Number of retired or separated participants receiving benefits 2018-01-01 0
Number of other retired or separated participants entitled to future benefits 2018-01-01 84
Total of all active and inactive participants 2018-01-01 192
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2018-01-01 0
Total participants 2018-01-01 192
Number of participants with account balances 2018-01-01 184
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2018-01-01 0
2017: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2017 401k membership
Total participants, beginning-of-year 2017-01-01 192
Total number of active participants reported on line 7a of the Form 5500 2017-01-01 111
Number of retired or separated participants receiving benefits 2017-01-01 0
Number of other retired or separated participants entitled to future benefits 2017-01-01 81
Total of all active and inactive participants 2017-01-01 192
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2017-01-01 0
Total participants 2017-01-01 192
Number of participants with account balances 2017-01-01 183
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2017-01-01 0
2016: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2016 401k membership
Total participants, beginning-of-year 2016-01-01 194
Total number of active participants reported on line 7a of the Form 5500 2016-01-01 110
Number of retired or separated participants receiving benefits 2016-01-01 0
Number of other retired or separated participants entitled to future benefits 2016-01-01 82
Total of all active and inactive participants 2016-01-01 192
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2016-01-01 0
Total participants 2016-01-01 192
Number of participants with account balances 2016-01-01 184
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2016-01-01 0
2015: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2015 401k membership
Total participants, beginning-of-year 2015-01-01 199
Total number of active participants reported on line 7a of the Form 5500 2015-01-01 113
Number of retired or separated participants receiving benefits 2015-01-01 0
Number of other retired or separated participants entitled to future benefits 2015-01-01 81
Total of all active and inactive participants 2015-01-01 194
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2015-01-01 0
Total participants 2015-01-01 194
Number of participants with account balances 2015-01-01 186
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2015-01-01 0
2014: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2014 401k membership
Total participants, beginning-of-year 2014-01-01 190
Total number of active participants reported on line 7a of the Form 5500 2014-01-01 119
Number of retired or separated participants receiving benefits 2014-01-01 0
Number of other retired or separated participants entitled to future benefits 2014-01-01 80
Total of all active and inactive participants 2014-01-01 199
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2014-01-01 0
Total participants 2014-01-01 199
Number of participants with account balances 2014-01-01 191
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2014-01-01 0
2013: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2013 401k membership
Total participants, beginning-of-year 2013-01-01 205
Total number of active participants reported on line 7a of the Form 5500 2013-01-01 139
Number of retired or separated participants receiving benefits 2013-01-01 0
Number of other retired or separated participants entitled to future benefits 2013-01-01 74
Total of all active and inactive participants 2013-01-01 213
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2013-01-01 0
Total participants 2013-01-01 213
Number of participants with account balances 2013-01-01 179
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2013-01-01 0
2012: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2012 401k membership
Total participants, beginning-of-year 2012-01-01 210
Total number of active participants reported on line 7a of the Form 5500 2012-01-01 131
Number of retired or separated participants receiving benefits 2012-01-01 0
Number of other retired or separated participants entitled to future benefits 2012-01-01 74
Total of all active and inactive participants 2012-01-01 205
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2012-01-01 0
Total participants 2012-01-01 205
Number of participants with account balances 2012-01-01 175
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2012-01-01 0
2011: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2011 401k membership
Total participants, beginning-of-year 2011-01-01 209
Total number of active participants reported on line 7a of the Form 5500 2011-01-01 150
Number of other retired or separated participants entitled to future benefits 2011-01-01 60
Total of all active and inactive participants 2011-01-01 210
Total participants 2011-01-01 210
Number of participants with account balances 2011-01-01 171
2009: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2009 401k membership
Total participants, beginning-of-year 2009-01-01 217
Total number of active participants reported on line 7a of the Form 5500 2009-01-01 162
Number of retired or separated participants receiving benefits 2009-01-01 0
Number of other retired or separated participants entitled to future benefits 2009-01-01 42
Total of all active and inactive participants 2009-01-01 204
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2009-01-01 0
Total participants 2009-01-01 204
Number of participants with account balances 2009-01-01 177
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2009-01-01 0

Measure	Date	Value
2022: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2022 401k membership
Total participants, beginning-of-year	2022-01-01	198
Total number of active participants reported on line 7a of the Form 5500	2022-01-01	103
Number of retired or separated participants receiving benefits	2022-01-01	0
Number of other retired or separated participants entitled to future benefits	2022-01-01	93
Total of all active and inactive participants	2022-01-01	196
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2022-01-01	0
Total participants	2022-01-01	196
Number of participants with account balances	2022-01-01	187
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2022-01-01	0
2021: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2021 401k membership
Total participants, beginning-of-year	2021-01-01	196
Total number of active participants reported on line 7a of the Form 5500	2021-01-01	106
Number of retired or separated participants receiving benefits	2021-01-01	0
Number of other retired or separated participants entitled to future benefits	2021-01-01	92
Total of all active and inactive participants	2021-01-01	198
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2021-01-01	0
Total participants	2021-01-01	198
Number of participants with account balances	2021-01-01	190
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2021-01-01	0
2020: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2020 401k membership
Total participants, beginning-of-year	2020-01-01	202
Total number of active participants reported on line 7a of the Form 5500	2020-01-01	102
Number of retired or separated participants receiving benefits	2020-01-01	0
Number of other retired or separated participants entitled to future benefits	2020-01-01	94
Total of all active and inactive participants	2020-01-01	196
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2020-01-01	0
Total participants	2020-01-01	196
Number of participants with account balances	2020-01-01	188
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2020-01-01	0
2019: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2019 401k membership
Total participants, beginning-of-year	2019-01-01	192
Total number of active participants reported on line 7a of the Form 5500	2019-01-01	107
Number of retired or separated participants receiving benefits	2019-01-01	0
Number of other retired or separated participants entitled to future benefits	2019-01-01	96
Total of all active and inactive participants	2019-01-01	203
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2019-01-01	0
Total participants	2019-01-01	203
Number of participants with account balances	2019-01-01	191
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2019-01-01	0
2018: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2018 401k membership
Total participants, beginning-of-year	2018-01-01	192
Total number of active participants reported on line 7a of the Form 5500	2018-01-01	108
Number of retired or separated participants receiving benefits	2018-01-01	0
Number of other retired or separated participants entitled to future benefits	2018-01-01	84
Total of all active and inactive participants	2018-01-01	192
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2018-01-01	0
Total participants	2018-01-01	192
Number of participants with account balances	2018-01-01	184
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2018-01-01	0
2017: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2017 401k membership
Total participants, beginning-of-year	2017-01-01	192
Total number of active participants reported on line 7a of the Form 5500	2017-01-01	111
Number of retired or separated participants receiving benefits	2017-01-01	0
Number of other retired or separated participants entitled to future benefits	2017-01-01	81
Total of all active and inactive participants	2017-01-01	192
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2017-01-01	0
Total participants	2017-01-01	192
Number of participants with account balances	2017-01-01	183
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2017-01-01	0
2016: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2016 401k membership
Total participants, beginning-of-year	2016-01-01	194
Total number of active participants reported on line 7a of the Form 5500	2016-01-01	110
Number of retired or separated participants receiving benefits	2016-01-01	0
Number of other retired or separated participants entitled to future benefits	2016-01-01	82
Total of all active and inactive participants	2016-01-01	192
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2016-01-01	0
Total participants	2016-01-01	192
Number of participants with account balances	2016-01-01	184
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2016-01-01	0
2015: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2015 401k membership
Total participants, beginning-of-year	2015-01-01	199
Total number of active participants reported on line 7a of the Form 5500	2015-01-01	113
Number of retired or separated participants receiving benefits	2015-01-01	0
Number of other retired or separated participants entitled to future benefits	2015-01-01	81
Total of all active and inactive participants	2015-01-01	194
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2015-01-01	0
Total participants	2015-01-01	194
Number of participants with account balances	2015-01-01	186
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2015-01-01	0
2014: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2014 401k membership
Total participants, beginning-of-year	2014-01-01	190
Total number of active participants reported on line 7a of the Form 5500	2014-01-01	119
Number of retired or separated participants receiving benefits	2014-01-01	0
Number of other retired or separated participants entitled to future benefits	2014-01-01	80
Total of all active and inactive participants	2014-01-01	199
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2014-01-01	0
Total participants	2014-01-01	199
Number of participants with account balances	2014-01-01	191
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2014-01-01	0
2013: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2013 401k membership
Total participants, beginning-of-year	2013-01-01	205
Total number of active participants reported on line 7a of the Form 5500	2013-01-01	139
Number of retired or separated participants receiving benefits	2013-01-01	0
Number of other retired or separated participants entitled to future benefits	2013-01-01	74
Total of all active and inactive participants	2013-01-01	213
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2013-01-01	0
Total participants	2013-01-01	213
Number of participants with account balances	2013-01-01	179
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2013-01-01	0
2012: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2012 401k membership
Total participants, beginning-of-year	2012-01-01	210
Total number of active participants reported on line 7a of the Form 5500	2012-01-01	131
Number of retired or separated participants receiving benefits	2012-01-01	0
Number of other retired or separated participants entitled to future benefits	2012-01-01	74
Total of all active and inactive participants	2012-01-01	205
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2012-01-01	0
Total participants	2012-01-01	205
Number of participants with account balances	2012-01-01	175
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2012-01-01	0
2011: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2011 401k membership
Total participants, beginning-of-year	2011-01-01	209
Total number of active participants reported on line 7a of the Form 5500	2011-01-01	150
Number of other retired or separated participants entitled to future benefits	2011-01-01	60
Total of all active and inactive participants	2011-01-01	210
Total participants	2011-01-01	210
Number of participants with account balances	2011-01-01	171
2009: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2009 401k membership
Total participants, beginning-of-year	2009-01-01	217
Total number of active participants reported on line 7a of the Form 5500	2009-01-01	162
Number of retired or separated participants receiving benefits	2009-01-01	0
Number of other retired or separated participants entitled to future benefits	2009-01-01	42
Total of all active and inactive participants	2009-01-01	204
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2009-01-01	0
Total participants	2009-01-01	204
Number of participants with account balances	2009-01-01	177
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2009-01-01	0

Financial Data on AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN

Measure	Date	Value
2022 : AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2022 401k financial data
Total unrealized appreciation/depreciation of assets	2022-12-31	$0
Total transfer of assets to this plan	2022-12-31	$0
Total transfer of assets from this plan	2022-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2022-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2022-12-31	$0
Total income from all sources (including contributions)	2022-12-31	$-1,080,181
Total loss/gain on sale of assets	2022-12-31	$0
Total of all expenses incurred	2022-12-31	$324,378
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2022-12-31	$300,190
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2022-12-31	$1,386,650
Value of total assets at end of year	2022-12-31	$16,831,248
Value of total assets at beginning of year	2022-12-31	$18,235,807
Total of administrative expenses incurred including professional, contract, advisory and management fees	2022-12-31	$24,188
Total interest from all sources	2022-12-31	$112,926
Total dividends received (eg from common stock, registered investment company shares)	2022-12-31	$124,234
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2022-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2022-12-31	$124,234
Administrative expenses professional fees incurred	2022-12-31	$12,900
Was this plan covered by a fidelity bond	2022-12-31	Yes
Value of fidelity bond cover	2022-12-31	$500,000
If this is an individual account plan, was there a blackout period	2022-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2022-12-31	No
Contributions received from participants	2022-12-31	$926,513
Participant contributions at end of year	2022-12-31	$148,796
Participant contributions at beginning of year	2022-12-31	$185,455
Participant contributions at end of year	2022-12-31	$33,774
Participant contributions at beginning of year	2022-12-31	$30,581
Income. Received or receivable in cash from other sources (including rollovers)	2022-12-31	$460,137
Other income not declared elsewhere	2022-12-31	$20,694
Administrative expenses (other) incurred	2022-12-31	$11,288
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Value of net income/loss	2022-12-31	$-1,404,559
Value of net assets at end of year (total assets less liabilities)	2022-12-31	$16,831,248
Value of net assets at beginning of year (total assets less liabilities)	2022-12-31	$18,235,807
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2022-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2022-12-31	No
Were any leases to which the plan was party in default or uncollectible	2022-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2022-12-31	$12,897,977
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2022-12-31	$14,370,191
Value of interest in pooled separate accounts at end of year	2022-12-31	$587,004
Value of interest in pooled separate accounts at beginning of year	2022-12-31	$551,113
Interest on participant loans	2022-12-31	$7,670
Interest earned on other investments	2022-12-31	$105,256
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2022-12-31	$3,163,697
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2022-12-31	$3,098,467
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2022-12-31	$-2,769,990
Net investment gain/loss from pooled separate accounts	2022-12-31	$45,305
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2022-12-31	No
Was there a failure to transmit to the plan any participant contributions	2022-12-31	No
Has the plan failed to provide any benefit when due under the plan	2022-12-31	No
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2022-12-31	$300,190
Did the plan have assets held for investment	2022-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2022-12-31	No
Opinion of an independent qualified public accountant for this plan	2022-12-31	Unqualified
Accountancy firm name	2022-12-31	PLANTE & MORGAN, PLLC
Accountancy firm EIN	2022-12-31	381357951
2021 : AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2021 401k financial data
Total unrealized appreciation/depreciation of assets	2021-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-12-31	$0
Total income from all sources (including contributions)	2021-12-31	$3,024,235
Total loss/gain on sale of assets	2021-12-31	$0
Total of all expenses incurred	2021-12-31	$388,044
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2021-12-31	$371,476
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2021-12-31	$840,412
Value of total assets at end of year	2021-12-31	$18,235,807
Value of total assets at beginning of year	2021-12-31	$15,599,616
Total of administrative expenses incurred including professional, contract, advisory and management fees	2021-12-31	$16,568
Total interest from all sources	2021-12-31	$97,515
Total dividends received (eg from common stock, registered investment company shares)	2021-12-31	$110,568
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2021-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2021-12-31	$110,568
Administrative expenses professional fees incurred	2021-12-31	$5,300
Was this plan covered by a fidelity bond	2021-12-31	Yes
Value of fidelity bond cover	2021-12-31	$500,000
If this is an individual account plan, was there a blackout period	2021-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2021-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2021-12-31	No
Contributions received from participants	2021-12-31	$840,018
Participant contributions at end of year	2021-12-31	$185,455
Participant contributions at beginning of year	2021-12-31	$118,804
Participant contributions at end of year	2021-12-31	$30,581
Participant contributions at beginning of year	2021-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2021-12-31	$394
Other income not declared elsewhere	2021-12-31	$23,685
Administrative expenses (other) incurred	2021-12-31	$11,268
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Value of net income/loss	2021-12-31	$2,636,191
Value of net assets at end of year (total assets less liabilities)	2021-12-31	$18,235,807
Value of net assets at beginning of year (total assets less liabilities)	2021-12-31	$15,599,616
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2021-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2021-12-31	No
Were any leases to which the plan was party in default or uncollectible	2021-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2021-12-31	$14,370,191
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2021-12-31	$11,965,240
Value of interest in pooled separate accounts at end of year	2021-12-31	$551,113
Value of interest in pooled separate accounts at beginning of year	2021-12-31	$444,205
Interest on participant loans	2021-12-31	$5,240
Interest earned on other investments	2021-12-31	$92,275
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2021-12-31	$3,098,467
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2021-12-31	$3,071,367
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2021-12-31	$1,871,047
Net investment gain/loss from pooled separate accounts	2021-12-31	$81,008
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2021-12-31	No
Was there a failure to transmit to the plan any participant contributions	2021-12-31	No
Has the plan failed to provide any benefit when due under the plan	2021-12-31	No
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2021-12-31	$371,476
Did the plan have assets held for investment	2021-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2021-12-31	No
Opinion of an independent qualified public accountant for this plan	2021-12-31	Unqualified
Accountancy firm name	2021-12-31	PLANTE & MORAN, PLLC
Accountancy firm EIN	2021-12-31	381357951
2020 : AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2020 401k financial data
Total unrealized appreciation/depreciation of assets	2020-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$0
Total income from all sources (including contributions)	2020-12-31	$2,678,691
Total loss/gain on sale of assets	2020-12-31	$0
Total of all expenses incurred	2020-12-31	$363,446
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2020-12-31	$357,013
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2020-12-31	$788,730
Value of total assets at end of year	2020-12-31	$15,599,616
Value of total assets at beginning of year	2020-12-31	$13,284,371
Total of administrative expenses incurred including professional, contract, advisory and management fees	2020-12-31	$6,433
Total interest from all sources	2020-12-31	$99,810
Total dividends received (eg from common stock, registered investment company shares)	2020-12-31	$47,591
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2020-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2020-12-31	$47,591
Was this plan covered by a fidelity bond	2020-12-31	Yes
Value of fidelity bond cover	2020-12-31	$500,000
If this is an individual account plan, was there a blackout period	2020-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2020-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2020-12-31	No
Contributions received from participants	2020-12-31	$778,882
Participant contributions at end of year	2020-12-31	$118,804
Participant contributions at beginning of year	2020-12-31	$16,819
Participant contributions at end of year	2020-12-31	$0
Participant contributions at beginning of year	2020-12-31	$29,654
Income. Received or receivable in cash from other sources (including rollovers)	2020-12-31	$9,848
Other income not declared elsewhere	2020-12-31	$19,596
Administrative expenses (other) incurred	2020-12-31	$6,433
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Value of net income/loss	2020-12-31	$2,315,245
Value of net assets at end of year (total assets less liabilities)	2020-12-31	$15,599,616
Value of net assets at beginning of year (total assets less liabilities)	2020-12-31	$13,284,371
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2020-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2020-12-31	No
Were any leases to which the plan was party in default or uncollectible	2020-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2020-12-31	$11,965,240
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2020-12-31	$9,824,911
Value of interest in pooled separate accounts at end of year	2020-12-31	$444,205
Value of interest in pooled separate accounts at beginning of year	2020-12-31	$450,561
Interest on participant loans	2020-12-31	$2,595
Interest earned on other investments	2020-12-31	$97,215
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2020-12-31	$3,071,367
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2020-12-31	$2,962,426
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2020-12-31	$1,726,786
Net investment gain/loss from pooled separate accounts	2020-12-31	$-3,822
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2020-12-31	No
Was there a failure to transmit to the plan any participant contributions	2020-12-31	No
Has the plan failed to provide any benefit when due under the plan	2020-12-31	No
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2020-12-31	$357,013
Did the plan have assets held for investment	2020-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2020-12-31	No
Opinion of an independent qualified public accountant for this plan	2020-12-31	Disclaimer
Accountancy firm name	2020-12-31	PLANTE & MORAN, PLLC
Accountancy firm EIN	2020-12-31	381357951
2019 : AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2019 401k financial data
Total unrealized appreciation/depreciation of assets	2019-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total income from all sources (including contributions)	2019-12-31	$2,997,505
Total loss/gain on sale of assets	2019-12-31	$0
Total of all expenses incurred	2019-12-31	$1,079,625
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$1,076,804
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$912,359
Value of total assets at end of year	2019-12-31	$13,284,371
Value of total assets at beginning of year	2019-12-31	$11,366,491
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$2,821
Total interest from all sources	2019-12-31	$96,277
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$33,220
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$33,220
Was this plan covered by a fidelity bond	2019-12-31	Yes
Value of fidelity bond cover	2019-12-31	$500,000
If this is an individual account plan, was there a blackout period	2019-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2019-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Contributions received from participants	2019-12-31	$749,222
Participant contributions at end of year	2019-12-31	$16,819
Participant contributions at beginning of year	2019-12-31	$0
Participant contributions at end of year	2019-12-31	$29,654
Participant contributions at beginning of year	2019-12-31	$28,405
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$163,137
Other income not declared elsewhere	2019-12-31	$18,136
Administrative expenses (other) incurred	2019-12-31	$2,821
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Value of net income/loss	2019-12-31	$1,917,880
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$13,284,371
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$11,366,491
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-12-31	$9,824,911
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-12-31	$8,055,241
Value of interest in pooled separate accounts at end of year	2019-12-31	$450,561
Value of interest in pooled separate accounts at beginning of year	2019-12-31	$453,255
Interest on participant loans	2019-12-31	$811
Interest earned on other investments	2019-12-31	$95,466
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2019-12-31	$2,962,426
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2019-12-31	$2,829,590
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$1,912,869
Net investment gain/loss from pooled separate accounts	2019-12-31	$24,644
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$1,076,804
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Accountancy firm name	2019-12-31	PLANTE & MORAN, PLLC
Accountancy firm EIN	2019-12-31	381357951
2018 : AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2018 401k financial data
Total unrealized appreciation/depreciation of assets	2018-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total income from all sources (including contributions)	2018-12-31	$397,853
Total loss/gain on sale of assets	2018-12-31	$0
Total of all expenses incurred	2018-12-31	$574,770
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2018-12-31	$574,509
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2018-12-31	$1,001,008
Value of total assets at end of year	2018-12-31	$11,366,491
Value of total assets at beginning of year	2018-12-31	$11,543,408
Total of administrative expenses incurred including professional, contract, advisory and management fees	2018-12-31	$261
Total interest from all sources	2018-12-31	$86,024
Total dividends received (eg from common stock, registered investment company shares)	2018-12-31	$6,491
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2018-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2018-12-31	$6,491
Was this plan covered by a fidelity bond	2018-12-31	Yes
Value of fidelity bond cover	2018-12-31	$500,000
If this is an individual account plan, was there a blackout period	2018-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2018-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2018-12-31	No
Contributions received from participants	2018-12-31	$698,413
Participant contributions at end of year	2018-12-31	$28,405
Participant contributions at beginning of year	2018-12-31	$24,775
Income. Received or receivable in cash from other sources (including rollovers)	2018-12-31	$302,595
Other income not declared elsewhere	2018-12-31	$6,982
Administrative expenses (other) incurred	2018-12-31	$261
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Value of net income/loss	2018-12-31	$-176,917
Value of net assets at end of year (total assets less liabilities)	2018-12-31	$11,366,491
Value of net assets at beginning of year (total assets less liabilities)	2018-12-31	$11,543,408
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2018-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2018-12-31	No
Were any leases to which the plan was party in default or uncollectible	2018-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2018-12-31	$8,055,241
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2018-12-31	$8,501,154
Value of interest in pooled separate accounts at end of year	2018-12-31	$453,255
Value of interest in pooled separate accounts at beginning of year	2018-12-31	$463,788
Interest earned on other investments	2018-12-31	$86,024
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2018-12-31	$2,829,590
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2018-12-31	$2,553,691
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2018-12-31	$-724,859
Net investment gain/loss from pooled separate accounts	2018-12-31	$22,207
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2018-12-31	No
Was there a failure to transmit to the plan any participant contributions	2018-12-31	No
Has the plan failed to provide any benefit when due under the plan	2018-12-31	No
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2018-12-31	$574,509
Did the plan have assets held for investment	2018-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2018-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2018-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2018-12-31	Disclaimer
Accountancy firm name	2018-12-31	PLANTE & MORAN, PLLC
Accountancy firm EIN	2018-12-31	381357951
2017 : AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2017 401k financial data
Total unrealized appreciation/depreciation of assets	2017-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total income from all sources (including contributions)	2017-12-31	$2,212,202
Total loss/gain on sale of assets	2017-12-31	$0
Total of all expenses incurred	2017-12-31	$1,004,123
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2017-12-31	$1,004,123
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2017-12-31	$663,418
Value of total assets at end of year	2017-12-31	$11,543,408
Value of total assets at beginning of year	2017-12-31	$10,335,329
Total of administrative expenses incurred including professional, contract, advisory and management fees	2017-12-31	$0
Total interest from all sources	2017-12-31	$79,650
Total dividends received (eg from common stock, registered investment company shares)	2017-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2017-12-31	No
Was this plan covered by a fidelity bond	2017-12-31	Yes
Value of fidelity bond cover	2017-12-31	$500,000
If this is an individual account plan, was there a blackout period	2017-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2017-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2017-12-31	No
Contributions received from participants	2017-12-31	$644,894
Participant contributions at end of year	2017-12-31	$24,775
Participant contributions at beginning of year	2017-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2017-12-31	$18,524
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Value of net income/loss	2017-12-31	$1,208,079
Value of net assets at end of year (total assets less liabilities)	2017-12-31	$11,543,408
Value of net assets at beginning of year (total assets less liabilities)	2017-12-31	$10,335,329
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2017-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2017-12-31	No
Were any leases to which the plan was party in default or uncollectible	2017-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2017-12-31	$8,501,154
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2017-12-31	$7,377,853
Value of interest in pooled separate accounts at end of year	2017-12-31	$463,788
Value of interest in pooled separate accounts at beginning of year	2017-12-31	$459,707
Interest earned on other investments	2017-12-31	$79,650
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2017-12-31	$2,553,691
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2017-12-31	$2,497,769
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2017-12-31	$1,449,712
Net investment gain/loss from pooled separate accounts	2017-12-31	$19,422
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2017-12-31	No
Was there a failure to transmit to the plan any participant contributions	2017-12-31	No
Has the plan failed to provide any benefit when due under the plan	2017-12-31	No
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2017-12-31	$1,004,123
Did the plan have assets held for investment	2017-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2017-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2017-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2017-12-31	Disclaimer
Accountancy firm name	2017-12-31	PLANTE & MORAN, PLLC
Accountancy firm EIN	2017-12-31	381357951
2016 : AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2016 401k financial data
Total unrealized appreciation/depreciation of assets	2016-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$0
Total income from all sources (including contributions)	2016-12-31	$1,697,375
Total loss/gain on sale of assets	2016-12-31	$0
Total of all expenses incurred	2016-12-31	$798,340
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2016-12-31	$798,340
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2016-12-31	$1,096,859
Value of total assets at end of year	2016-12-31	$10,335,329
Value of total assets at beginning of year	2016-12-31	$9,436,294
Total of administrative expenses incurred including professional, contract, advisory and management fees	2016-12-31	$0
Total interest from all sources	2016-12-31	$87,133
Total dividends received (eg from common stock, registered investment company shares)	2016-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2016-12-31	No
Was this plan covered by a fidelity bond	2016-12-31	Yes
Value of fidelity bond cover	2016-12-31	$500,000
If this is an individual account plan, was there a blackout period	2016-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2016-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2016-12-31	No
Contributions received from participants	2016-12-31	$622,641
Participant contributions at end of year	2016-12-31	$0
Participant contributions at beginning of year	2016-12-31	$25,881
Income. Received or receivable in cash from other sources (including rollovers)	2016-12-31	$474,218
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Value of net income/loss	2016-12-31	$899,035
Value of net assets at end of year (total assets less liabilities)	2016-12-31	$10,335,329
Value of net assets at beginning of year (total assets less liabilities)	2016-12-31	$9,436,294
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2016-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2016-12-31	No
Were any leases to which the plan was party in default or uncollectible	2016-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2016-12-31	$7,377,853
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2016-12-31	$6,491,227
Value of interest in pooled separate accounts at end of year	2016-12-31	$459,707
Value of interest in pooled separate accounts at beginning of year	2016-12-31	$451,063
Interest earned on other investments	2016-12-31	$87,133
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2016-12-31	$2,497,769
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2016-12-31	$2,468,123
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2016-12-31	$490,714
Net investment gain/loss from pooled separate accounts	2016-12-31	$22,669
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2016-12-31	No
Was there a failure to transmit to the plan any participant contributions	2016-12-31	No
Has the plan failed to provide any benefit when due under the plan	2016-12-31	No
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2016-12-31	$798,340
Did the plan have assets held for investment	2016-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2016-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2016-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2016-12-31	Disclaimer
Accountancy firm name	2016-12-31	PLANTE & MORAN, PLLC
Accountancy firm EIN	2016-12-31	381357951
2015 : AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2015 401k financial data
Total unrealized appreciation/depreciation of assets	2015-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-31	$0
Total income from all sources (including contributions)	2015-12-31	$853,865
Total loss/gain on sale of assets	2015-12-31	$0
Total of all expenses incurred	2015-12-31	$797,726
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2015-12-31	$797,726
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2015-12-31	$766,654
Value of total assets at end of year	2015-12-31	$9,436,294
Value of total assets at beginning of year	2015-12-31	$9,380,155
Total of administrative expenses incurred including professional, contract, advisory and management fees	2015-12-31	$0
Total interest from all sources	2015-12-31	$76,759
Total dividends received (eg from common stock, registered investment company shares)	2015-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2015-12-31	No
Was this plan covered by a fidelity bond	2015-12-31	Yes
Value of fidelity bond cover	2015-12-31	$500,000
If this is an individual account plan, was there a blackout period	2015-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2015-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2015-12-31	No
Contributions received from participants	2015-12-31	$687,332
Participant contributions at end of year	2015-12-31	$25,881
Participant contributions at beginning of year	2015-12-31	$24,324
Income. Received or receivable in cash from other sources (including rollovers)	2015-12-31	$79,322
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2015-12-31	$3,895
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Value of net income/loss	2015-12-31	$56,139
Value of net assets at end of year (total assets less liabilities)	2015-12-31	$9,436,294
Value of net assets at beginning of year (total assets less liabilities)	2015-12-31	$9,380,155
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2015-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2015-12-31	No
Were any leases to which the plan was party in default or uncollectible	2015-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2015-12-31	$6,491,227
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2015-12-31	$6,669,255
Value of interest in pooled separate accounts at end of year	2015-12-31	$451,063
Value of interest in pooled separate accounts at beginning of year	2015-12-31	$414,191
Interest earned on other investments	2015-12-31	$76,759
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2015-12-31	$2,468,123
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2015-12-31	$2,272,385
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2015-12-31	$-24,388
Net investment gain/loss from pooled separate accounts	2015-12-31	$34,840
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2015-12-31	No
Was there a failure to transmit to the plan any participant contributions	2015-12-31	No
Has the plan failed to provide any benefit when due under the plan	2015-12-31	No
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2015-12-31	$793,831
Did the plan have assets held for investment	2015-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2015-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2015-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2015-12-31	Disclaimer
Accountancy firm name	2015-12-31	PLANTE & MORAN, PLLC
Accountancy firm EIN	2015-12-31	381357951
2014 : AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2014 401k financial data
Total unrealized appreciation/depreciation of assets	2014-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$0
Total income from all sources (including contributions)	2014-12-31	$1,324,752
Total loss/gain on sale of assets	2014-12-31	$0
Total of all expenses incurred	2014-12-31	$216,983
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2014-12-31	$216,983
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2014-12-31	$808,294
Value of total assets at end of year	2014-12-31	$9,380,155
Value of total assets at beginning of year	2014-12-31	$8,272,386
Total of administrative expenses incurred including professional, contract, advisory and management fees	2014-12-31	$0
Total interest from all sources	2014-12-31	$73,176
Total dividends received (eg from common stock, registered investment company shares)	2014-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2014-12-31	No
Was this plan covered by a fidelity bond	2014-12-31	Yes
Value of fidelity bond cover	2014-12-31	$500,000
If this is an individual account plan, was there a blackout period	2014-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2014-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2014-12-31	No
Contributions received from participants	2014-12-31	$619,854
Participant contributions at end of year	2014-12-31	$24,324
Participant contributions at beginning of year	2014-12-31	$19,955
Income. Received or receivable in cash from other sources (including rollovers)	2014-12-31	$188,440
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Value of net income/loss	2014-12-31	$1,107,769
Value of net assets at end of year (total assets less liabilities)	2014-12-31	$9,380,155
Value of net assets at beginning of year (total assets less liabilities)	2014-12-31	$8,272,386
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2014-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2014-12-31	No
Were any leases to which the plan was party in default or uncollectible	2014-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2014-12-31	$6,669,255
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2014-12-31	$5,894,500
Value of interest in pooled separate accounts at end of year	2014-12-31	$414,191
Value of interest in pooled separate accounts at beginning of year	2014-12-31	$377,434
Interest earned on other investments	2014-12-31	$73,176
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2014-12-31	$2,272,385
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2014-12-31	$1,980,497
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2014-12-31	$398,876
Net investment gain/loss from pooled separate accounts	2014-12-31	$44,406
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2014-12-31	No
Was there a failure to transmit to the plan any participant contributions	2014-12-31	No
Has the plan failed to provide any benefit when due under the plan	2014-12-31	No
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2014-12-31	$216,983
Did the plan have assets held for investment	2014-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2014-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2014-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2014-12-31	Disclaimer
Accountancy firm name	2014-12-31	PLANTE & MORAN, PLLC
Accountancy firm EIN	2014-12-31	381357951
2013 : AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2013 401k financial data
Total unrealized appreciation/depreciation of assets	2013-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2013-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2013-12-31	$0
Total income from all sources (including contributions)	2013-12-31	$1,864,997
Total loss/gain on sale of assets	2013-12-31	$0
Total of all expenses incurred	2013-12-31	$494,374
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2013-12-31	$494,374
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2013-12-31	$682,911
Value of total assets at end of year	2013-12-31	$8,272,386
Value of total assets at beginning of year	2013-12-31	$6,901,763
Total of administrative expenses incurred including professional, contract, advisory and management fees	2013-12-31	$0
Total interest from all sources	2013-12-31	$55,870
Total dividends received (eg from common stock, registered investment company shares)	2013-12-31	$8,701
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2013-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2013-12-31	$8,701
Was this plan covered by a fidelity bond	2013-12-31	Yes
Value of fidelity bond cover	2013-12-31	$500,000
If this is an individual account plan, was there a blackout period	2013-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2013-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2013-12-31	No
Contributions received from participants	2013-12-31	$572,069
Participant contributions at end of year	2013-12-31	$19,955
Participant contributions at beginning of year	2013-12-31	$18,709
Income. Received or receivable in cash from other sources (including rollovers)	2013-12-31	$110,842
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Value of net income/loss	2013-12-31	$1,370,623
Value of net assets at end of year (total assets less liabilities)	2013-12-31	$8,272,386
Value of net assets at beginning of year (total assets less liabilities)	2013-12-31	$6,901,763
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2013-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2013-12-31	No
Were any leases to which the plan was party in default or uncollectible	2013-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2013-12-31	$5,894,500
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2013-12-31	$4,680,464
Value of interest in pooled separate accounts at end of year	2013-12-31	$377,434
Value of interest in pooled separate accounts at beginning of year	2013-12-31	$341,478
Interest earned on other investments	2013-12-31	$55,870
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2013-12-31	$1,980,497
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2013-12-31	$1,861,112
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2013-12-31	$1,086,486
Net investment gain/loss from pooled separate accounts	2013-12-31	$31,029
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2013-12-31	No
Was there a failure to transmit to the plan any participant contributions	2013-12-31	No
Has the plan failed to provide any benefit when due under the plan	2013-12-31	No
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2013-12-31	$494,374
Did the plan have assets held for investment	2013-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2013-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2013-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2013-12-31	Disclaimer
Accountancy firm name	2013-12-31	PLANTE & MORAN, PLLC
Accountancy firm EIN	2013-12-31	381357951
2012 : AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2012 401k financial data
Total unrealized appreciation/depreciation of assets	2012-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2012-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2012-12-31	$0
Total income from all sources (including contributions)	2012-12-31	$1,322,058
Total loss/gain on sale of assets	2012-12-31	$0
Total of all expenses incurred	2012-12-31	$536,994
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2012-12-31	$536,994
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2012-12-31	$659,496
Value of total assets at end of year	2012-12-31	$6,901,763
Value of total assets at beginning of year	2012-12-31	$6,116,699
Total of administrative expenses incurred including professional, contract, advisory and management fees	2012-12-31	$0
Total interest from all sources	2012-12-31	$52,496
Total dividends received (eg from common stock, registered investment company shares)	2012-12-31	$7,430
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2012-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2012-12-31	$7,430
Was this plan covered by a fidelity bond	2012-12-31	Yes
Value of fidelity bond cover	2012-12-31	$500,000
If this is an individual account plan, was there a blackout period	2012-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2012-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2012-12-31	No
Contributions received from participants	2012-12-31	$570,247
Participant contributions at end of year	2012-12-31	$18,709
Participant contributions at beginning of year	2012-12-31	$19,299
Income. Received or receivable in cash from other sources (including rollovers)	2012-12-31	$89,249
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2012-12-31	No
Value of net income/loss	2012-12-31	$785,064
Value of net assets at end of year (total assets less liabilities)	2012-12-31	$6,901,763
Value of net assets at beginning of year (total assets less liabilities)	2012-12-31	$6,116,699
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2012-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2012-12-31	No
Were any leases to which the plan was party in default or uncollectible	2012-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2012-12-31	$4,680,464
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2012-12-31	$4,075,805
Value of interest in pooled separate accounts at end of year	2012-12-31	$341,478
Value of interest in pooled separate accounts at beginning of year	2012-12-31	$280,779
Interest earned on other investments	2012-12-31	$52,496
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2012-12-31	$1,861,112
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2012-12-31	$1,740,816
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2012-12-31	$572,856
Net investment gain/loss from pooled separate accounts	2012-12-31	$29,780
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2012-12-31	No
Was there a failure to transmit to the plan any participant contributions	2012-12-31	No
Has the plan failed to provide any benefit when due under the plan	2012-12-31	No
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2012-12-31	$536,994
Did the plan have assets held for investment	2012-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2012-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2012-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2012-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2012-12-31	Disclaimer
Accountancy firm name	2012-12-31	PLANTE & MORAN, PLLC
Accountancy firm EIN	2012-12-31	381357951
2011 : AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2011 401k financial data
Total income from all sources (including contributions)	2011-12-31	$695,700
Total of all expenses incurred	2011-12-31	$598,227
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2011-12-31	$598,227
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2011-12-31	$675,176
Value of total assets at end of year	2011-12-31	$6,116,699
Value of total assets at beginning of year	2011-12-31	$6,019,226
Total interest from all sources	2011-12-31	$56,372
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2011-12-31	No
Was this plan covered by a fidelity bond	2011-12-31	Yes
Value of fidelity bond cover	2011-12-31	$500,000
If this is an individual account plan, was there a blackout period	2011-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2011-12-31	No
Contributions received from participants	2011-12-31	$675,176
Participant contributions at end of year	2011-12-31	$19,299
Participant contributions at beginning of year	2011-12-31	$22,652
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2011-12-31	No
Value of net income/loss	2011-12-31	$97,473
Value of net assets at end of year (total assets less liabilities)	2011-12-31	$6,116,699
Value of net assets at beginning of year (total assets less liabilities)	2011-12-31	$6,019,226
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2011-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2011-12-31	No
Were any leases to which the plan was party in default or uncollectible	2011-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2011-12-31	$4,075,805
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2011-12-31	$3,739,813
Value of interest in pooled separate accounts at end of year	2011-12-31	$280,779
Value of interest in pooled separate accounts at beginning of year	2011-12-31	$268,804
Interest earned on other investments	2011-12-31	$56,372
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2011-12-31	$502,644
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2011-12-31	$502,644
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2011-12-31	$1,740,816
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2011-12-31	$1,485,313
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2011-12-31	$-68,381
Net investment gain/loss from pooled separate accounts	2011-12-31	$32,533
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2011-12-31	No
Was there a failure to transmit to the plan any participant contributions	2011-12-31	No
Has the plan failed to provide any benefit when due under the plan	2011-12-31	No
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2011-12-31	$598,227
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2011-12-31	No
Did the plan have assets held for investment	2011-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2011-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2011-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2011-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2011-12-31	Disclaimer
Accountancy firm name	2011-12-31	PLANTE & MORAN, PLLC
Accountancy firm EIN	2011-12-31	381357951
2010 : AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2010 401k financial data
Total income from all sources (including contributions)	2010-12-31	$1,132,632
Total of all expenses incurred	2010-12-31	$462,810
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2010-12-31	$462,810
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2010-12-31	$612,630
Value of total assets at end of year	2010-12-31	$6,019,226
Value of total assets at beginning of year	2010-12-31	$5,349,404
Total interest from all sources	2010-12-31	$46,832
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2010-12-31	No
Was this plan covered by a fidelity bond	2010-12-31	Yes
Value of fidelity bond cover	2010-12-31	$500,000
If this is an individual account plan, was there a blackout period	2010-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2010-12-31	No
Contributions received from participants	2010-12-31	$612,630
Participant contributions at end of year	2010-12-31	$22,652
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2010-12-31	No
Value of net income/loss	2010-12-31	$669,822
Value of net assets at end of year (total assets less liabilities)	2010-12-31	$6,019,226
Value of net assets at beginning of year (total assets less liabilities)	2010-12-31	$5,349,404
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2010-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2010-12-31	No
Were any leases to which the plan was party in default or uncollectible	2010-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2010-12-31	$3,739,813
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2010-12-31	$3,034,691
Value of interest in pooled separate accounts at end of year	2010-12-31	$268,804
Value of interest in pooled separate accounts at beginning of year	2010-12-31	$253,604
Interest earned on other investments	2010-12-31	$46,832
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2010-12-31	$502,644
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2010-12-31	$527,894
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2010-12-31	$527,894
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2010-12-31	$1,485,313
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2010-12-31	$1,533,215
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2010-12-31	$441,038
Net investment gain/loss from pooled separate accounts	2010-12-31	$32,132
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2010-12-31	No
Was there a failure to transmit to the plan any participant contributions	2010-12-31	No
Has the plan failed to provide any benefit when due under the plan	2010-12-31	No
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2010-12-31	$462,810
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2010-12-31	No
Did the plan have assets held for investment	2010-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2010-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2010-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2010-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2010-12-31	Disclaimer
Accountancy firm name	2010-12-31	BLACKMAN KALLICK, LLP
Accountancy firm EIN	2010-12-31	363468829

Form 5500 Responses for AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN

2022: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2022 form 5500 responses
2022-01-01	Type of plan entity	Single employer plan
2022-01-01	Submission has been amended	No
2022-01-01	This submission is the final filing	No
2022-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2022-01-01	Plan is a collectively bargained plan	No
2022-01-01	Plan funding arrangement – Insurance	Yes
2022-01-01	Plan funding arrangement – Trust	Yes
2022-01-01	Plan benefit arrangement – Insurance	Yes
2022-01-01	Plan benefit arrangement - Trust	Yes
2021: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2021 form 5500 responses
2021-01-01	Type of plan entity	Single employer plan
2021-01-01	Submission has been amended	No
2021-01-01	This submission is the final filing	No
2021-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2021-01-01	Plan is a collectively bargained plan	No
2021-01-01	Plan funding arrangement – Insurance	Yes
2021-01-01	Plan funding arrangement – Trust	Yes
2021-01-01	Plan benefit arrangement – Insurance	Yes
2021-01-01	Plan benefit arrangement - Trust	Yes
2020: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2020 form 5500 responses
2020-01-01	Type of plan entity	Single employer plan
2020-01-01	Submission has been amended	No
2020-01-01	This submission is the final filing	No
2020-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2020-01-01	Plan is a collectively bargained plan	No
2020-01-01	Plan funding arrangement – Insurance	Yes
2020-01-01	Plan funding arrangement – Trust	Yes
2020-01-01	Plan benefit arrangement – Insurance	Yes
2020-01-01	Plan benefit arrangement - Trust	Yes
2019: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2019 form 5500 responses
2019-01-01	Type of plan entity	Single employer plan
2019-01-01	Submission has been amended	No
2019-01-01	This submission is the final filing	No
2019-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2019-01-01	Plan is a collectively bargained plan	No
2019-01-01	Plan funding arrangement – Insurance	Yes
2019-01-01	Plan funding arrangement – Trust	Yes
2019-01-01	Plan benefit arrangement – Insurance	Yes
2019-01-01	Plan benefit arrangement - Trust	Yes
2018: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2018 form 5500 responses
2018-01-01	Type of plan entity	Single employer plan
2018-01-01	Submission has been amended	No
2018-01-01	This submission is the final filing	No
2018-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2018-01-01	Plan is a collectively bargained plan	No
2018-01-01	Plan funding arrangement – Insurance	Yes
2018-01-01	Plan funding arrangement – Trust	Yes
2018-01-01	Plan benefit arrangement – Insurance	Yes
2018-01-01	Plan benefit arrangement - Trust	Yes
2017: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2017 form 5500 responses
2017-01-01	Type of plan entity	Single employer plan
2017-01-01	Submission has been amended	No
2017-01-01	This submission is the final filing	No
2017-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2017-01-01	Plan is a collectively bargained plan	No
2017-01-01	Plan funding arrangement – Insurance	Yes
2017-01-01	Plan funding arrangement – Trust	Yes
2017-01-01	Plan benefit arrangement – Insurance	Yes
2017-01-01	Plan benefit arrangement - Trust	Yes
2016: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2016 form 5500 responses
2016-01-01	Type of plan entity	Single employer plan
2016-01-01	Submission has been amended	No
2016-01-01	This submission is the final filing	No
2016-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2016-01-01	Plan is a collectively bargained plan	No
2016-01-01	Plan funding arrangement – Insurance	Yes
2016-01-01	Plan funding arrangement – Trust	Yes
2016-01-01	Plan benefit arrangement – Insurance	Yes
2016-01-01	Plan benefit arrangement - Trust	Yes
2015: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2015 form 5500 responses
2015-01-01	Type of plan entity	Single employer plan
2015-01-01	Submission has been amended	No
2015-01-01	This submission is the final filing	No
2015-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2015-01-01	Plan is a collectively bargained plan	No
2015-01-01	Plan funding arrangement – Insurance	Yes
2015-01-01	Plan funding arrangement – Trust	Yes
2015-01-01	Plan benefit arrangement – Insurance	Yes
2015-01-01	Plan benefit arrangement - Trust	Yes
2014: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2014 form 5500 responses
2014-01-01	Type of plan entity	Single employer plan
2014-01-01	Submission has been amended	No
2014-01-01	This submission is the final filing	No
2014-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2014-01-01	Plan is a collectively bargained plan	No
2014-01-01	Plan funding arrangement – Insurance	Yes
2014-01-01	Plan funding arrangement – Trust	Yes
2014-01-01	Plan benefit arrangement – Insurance	Yes
2014-01-01	Plan benefit arrangement - Trust	Yes
2013: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2013 form 5500 responses
2013-01-01	Type of plan entity	Single employer plan
2013-01-01	Submission has been amended	No
2013-01-01	This submission is the final filing	No
2013-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2013-01-01	Plan is a collectively bargained plan	No
2013-01-01	Plan funding arrangement – Insurance	Yes
2013-01-01	Plan funding arrangement – Trust	Yes
2013-01-01	Plan benefit arrangement – Insurance	Yes
2013-01-01	Plan benefit arrangement - Trust	Yes
2012: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2012 form 5500 responses
2012-01-01	Type of plan entity	Single employer plan
2012-01-01	Submission has been amended	No
2012-01-01	This submission is the final filing	No
2012-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2012-01-01	Plan is a collectively bargained plan	No
2012-01-01	Plan funding arrangement – Insurance	Yes
2012-01-01	Plan funding arrangement – Trust	Yes
2012-01-01	Plan benefit arrangement – Insurance	Yes
2012-01-01	Plan benefit arrangement - Trust	Yes
2011: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2011 form 5500 responses
2011-01-01	Type of plan entity	Single employer plan
2011-01-01	Plan funding arrangement – Insurance	Yes
2011-01-01	Plan funding arrangement – Trust	Yes
2011-01-01	Plan benefit arrangement – Insurance	Yes
2011-01-01	Plan benefit arrangement - Trust	Yes
2009: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2009 form 5500 responses
2009-01-01	Type of plan entity	Single employer plan
2009-01-01	First time form 5500 has been submitted	Yes
2009-01-01	This submission is the final filing	No
2009-01-01	Plan funding arrangement – Insurance	Yes
2009-01-01	Plan funding arrangement – Trust	Yes
2009-01-01	Plan benefit arrangement – Insurance	Yes
2009-01-01	Plan benefit arrangement - Trust	Yes
2008: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2008 form 5500 responses
2008-01-01	Type of plan entity	Single employer plan
2008-01-01	This submission is the final filing	No
2007: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2007 form 5500 responses
2007-01-01	Type of plan entity	Single employer plan
2007-01-01	This submission is the final filing	No
2006: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2006 form 5500 responses
2006-01-01	Type of plan entity	Single employer plan
2006-01-01	This submission is the final filing	No
2005: AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 403(B) PLAN 2005 form 5500 responses
2005-01-01	Type of plan entity	Single employer plan
2005-01-01	First time form 5500 has been submitted	Yes
2005-01-01	This submission is the final filing	No

Insurance Providers Used on plan

TIAA-CREF (National Association of Insurance Commissioners NAIC id number: 69345 )

Policy contract number

346302

Policy instance

Insurance contract or identification number	346302
Number of Individuals Covered	153
Insurance policy start date	2022-01-01
Insurance policy end date	2022-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $0
Are there contracts with allocated funds for individual policies?	0
Are there contracts with allocated funds for group deferred annuity?	No
Are there contracts with allocated funds for types other than group deferred annuity or individual?	No
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?	No
Are there contracts with unallocated funds for contracts of type guaranteed investment?	Yes
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	No
Health Insurance Welfare Benefit	No
Dental Insurance Welfare Benefit	No
Vision Insurance Welfare Benefit	No
Life Insurance Welfare Benefit	No
Temporary Disability Insurance Welfare Benefit	No
Long Term Disability Insurance Welfare Benefit	No
Unemployment Insurance Welfare Benefit	No
Were dividends or retroactive rate refunds paid in cash?	No
Were dividends or retroactive rate refunds paid as a credit?	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

TIAA-CREF (National Association of Insurance Commissioners NAIC id number: 69345 )

Policy contract number

346302

Policy instance

Insurance contract or identification number	346302
Number of Individuals Covered	158
Insurance policy start date	2021-01-01
Insurance policy end date	2021-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $0
Are there contracts with allocated funds for individual policies?	0
Are there contracts with allocated funds for group deferred annuity?	No
Are there contracts with allocated funds for types other than group deferred annuity or individual?	No
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?	No
Are there contracts with unallocated funds for contracts of type guaranteed investment?	Yes
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	No
Health Insurance Welfare Benefit	No
Dental Insurance Welfare Benefit	No
Vision Insurance Welfare Benefit	No
Life Insurance Welfare Benefit	No
Temporary Disability Insurance Welfare Benefit	No
Long Term Disability Insurance Welfare Benefit	No
Unemployment Insurance Welfare Benefit	No
Were dividends or retroactive rate refunds paid in cash?	No
Were dividends or retroactive rate refunds paid as a credit?	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

TIAA-CREF (National Association of Insurance Commissioners NAIC id number: 69345 )

Policy contract number

346302

Policy instance

Insurance contract or identification number	346302
Number of Individuals Covered	166
Insurance policy start date	2020-01-01
Insurance policy end date	2020-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $0
Are there contracts with allocated funds for individual policies?	0
Are there contracts with allocated funds for group deferred annuity?	No
Are there contracts with allocated funds for types other than group deferred annuity or individual?	No
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?	No
Are there contracts with unallocated funds for contracts of type guaranteed investment?	Yes
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	No
Health Insurance Welfare Benefit	No
Dental Insurance Welfare Benefit	No
Vision Insurance Welfare Benefit	No
Life Insurance Welfare Benefit	No
Temporary Disability Insurance Welfare Benefit	No
Long Term Disability Insurance Welfare Benefit	No
Unemployment Insurance Welfare Benefit	No
Were dividends or retroactive rate refunds paid in cash?	No
Were dividends or retroactive rate refunds paid as a credit?	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

TIAA-CREF (National Association of Insurance Commissioners NAIC id number: 69345 )

Policy contract number

346302

Policy instance

Insurance contract or identification number	346302
Number of Individuals Covered	170
Insurance policy start date	2019-01-01
Insurance policy end date	2019-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $0
Are there contracts with allocated funds for individual policies?	0
Are there contracts with allocated funds for group deferred annuity?	No
Are there contracts with allocated funds for types other than group deferred annuity or individual?	No
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?	No
Are there contracts with unallocated funds for contracts of type guaranteed investment?	Yes
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	No
Health Insurance Welfare Benefit	No
Dental Insurance Welfare Benefit	No
Vision Insurance Welfare Benefit	No
Life Insurance Welfare Benefit	No
Temporary Disability Insurance Welfare Benefit	No
Long Term Disability Insurance Welfare Benefit	No
Unemployment Insurance Welfare Benefit	No
Were dividends or retroactive rate refunds paid in cash?	No
Were dividends or retroactive rate refunds paid as a credit?	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

TIAA-CREF (National Association of Insurance Commissioners NAIC id number: 69345 )

Policy contract number

346302

Policy instance

Insurance contract or identification number	346302
Number of Individuals Covered	176
Insurance policy start date	2018-01-01
Insurance policy end date	2018-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $0
Are there contracts with allocated funds for individual policies?	0
Are there contracts with allocated funds for group deferred annuity?	No
Are there contracts with allocated funds for types other than group deferred annuity or individual?	No
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?	No
Are there contracts with unallocated funds for contracts of type guaranteed investment?	Yes
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	No
Health Insurance Welfare Benefit	No
Dental Insurance Welfare Benefit	No
Vision Insurance Welfare Benefit	No
Life Insurance Welfare Benefit	No
Temporary Disability Insurance Welfare Benefit	No
Long Term Disability Insurance Welfare Benefit	No
Unemployment Insurance Welfare Benefit	No
Were dividends or retroactive rate refunds paid in cash?	No
Were dividends or retroactive rate refunds paid as a credit?	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

TIAA-CREF (National Association of Insurance Commissioners NAIC id number: 69345 )

Policy contract number

346302

Policy instance

Insurance contract or identification number	346302
Number of Individuals Covered	183
Insurance policy start date	2017-01-01
Insurance policy end date	2017-12-31
Are there contracts with allocated funds for individual policies?	0
Are there contracts with allocated funds for group deferred annuity?	No
Are there contracts with allocated funds for types other than group deferred annuity or individual?	Yes
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?	No
Are there contracts with unallocated funds for contracts of type guaranteed investment?	Yes
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	No
Health Insurance Welfare Benefit	No
Dental Insurance Welfare Benefit	No
Vision Insurance Welfare Benefit	No
Life Insurance Welfare Benefit	No
Temporary Disability Insurance Welfare Benefit	No
Long Term Disability Insurance Welfare Benefit	No
Unemployment Insurance Welfare Benefit	No
Were dividends or retroactive rate refunds paid in cash?	No
Were dividends or retroactive rate refunds paid as a credit?	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No
Other information about contract	GUARANTEED INVESTMENT

TIAA-CREF (National Association of Insurance Commissioners NAIC id number: 69345 )

Policy contract number

346302

Policy instance

Insurance contract or identification number	346302
Number of Individuals Covered	186
Insurance policy start date	2015-01-01
Insurance policy end date	2015-12-31
Are there contracts with allocated funds for individual policies?	No
Are there contracts with allocated funds for group deferred annuity?	No
Are there contracts with allocated funds for types other than group deferred annuity or individual?	No
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?	No
Are there contracts with unallocated funds for contracts of type guaranteed investment?	Yes
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	No
Health Insurance Welfare Benefit	No
Dental Insurance Welfare Benefit	No
Vision Insurance Welfare Benefit	No
Life Insurance Welfare Benefit	No
Temporary Disability Insurance Welfare Benefit	No
Long Term Disability Insurance Welfare Benefit	No
Unemployment Insurance Welfare Benefit	No
Were dividends or retroactive rate refunds paid in cash?	No
Were dividends or retroactive rate refunds paid as a credit?	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

TIAA-CREF (National Association of Insurance Commissioners NAIC id number: 69345 )

Policy contract number

346302

Policy instance

Insurance contract or identification number	346302
Number of Individuals Covered	191
Insurance policy start date	2014-01-01
Insurance policy end date	2014-12-31
Are there contracts with allocated funds for individual policies?	No
Are there contracts with allocated funds for group deferred annuity?	No
Are there contracts with allocated funds for types other than group deferred annuity or individual?	No
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?	No
Are there contracts with unallocated funds for contracts of type guaranteed investment?	Yes
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	No
Health Insurance Welfare Benefit	No
Dental Insurance Welfare Benefit	No
Vision Insurance Welfare Benefit	No
Life Insurance Welfare Benefit	No
Temporary Disability Insurance Welfare Benefit	No
Long Term Disability Insurance Welfare Benefit	No
Unemployment Insurance Welfare Benefit	No
Were dividends or retroactive rate refunds paid in cash?	No
Were dividends or retroactive rate refunds paid as a credit?	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

TIAA-CREF (National Association of Insurance Commissioners NAIC id number: 69345 )

Policy contract number

346302

Policy instance

Insurance contract or identification number	346302
Number of Individuals Covered	179
Insurance policy start date	2013-01-01
Insurance policy end date	2013-12-31
Are there contracts with allocated funds for individual policies?	No
Are there contracts with allocated funds for group deferred annuity?	No
Are there contracts with allocated funds for types other than group deferred annuity or individual?	No
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?	No
Are there contracts with unallocated funds for contracts of type guaranteed investment?	Yes
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	No
Health Insurance Welfare Benefit	No
Dental Insurance Welfare Benefit	No
Vision Insurance Welfare Benefit	No
Life Insurance Welfare Benefit	No
Temporary Disability Insurance Welfare Benefit	No
Long Term Disability Insurance Welfare Benefit	No
Unemployment Insurance Welfare Benefit	No
Were dividends or retroactive rate refunds paid in cash?	No
Were dividends or retroactive rate refunds paid as a credit?	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

TIAA-CREF (National Association of Insurance Commissioners NAIC id number: 69345 )

Policy contract number

346302

Policy instance

Insurance contract or identification number	346302
Number of Individuals Covered	175
Insurance policy start date	2012-01-01
Insurance policy end date	2012-12-31
Are there contracts with allocated funds for individual policies?	No
Are there contracts with allocated funds for group deferred annuity?	No
Are there contracts with allocated funds for types other than group deferred annuity or individual?	No
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?	No
Are there contracts with unallocated funds for contracts of type guaranteed investment?	Yes
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	No
Health Insurance Welfare Benefit	No
Dental Insurance Welfare Benefit	No
Vision Insurance Welfare Benefit	No
Life Insurance Welfare Benefit	No
Temporary Disability Insurance Welfare Benefit	No
Long Term Disability Insurance Welfare Benefit	No
Unemployment Insurance Welfare Benefit	No
Were dividends or retroactive rate refunds paid in cash?	No
Were dividends or retroactive rate refunds paid as a credit?	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

TIAA-CREF (National Association of Insurance Commissioners NAIC id number: 69345 )

Policy contract number

346302

Policy instance

Insurance contract or identification number	346302
Number of Individuals Covered	171
Insurance policy start date	2011-01-01
Insurance policy end date	2011-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $0
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type guaranteed investment?	Yes
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

TIAA-CREF (National Association of Insurance Commissioners NAIC id number: 69345 )

Policy contract number

346302

Policy instance

Insurance contract or identification number	346302
Number of Individuals Covered	209
Insurance policy start date	2010-01-01
Insurance policy end date	2010-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $0
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type guaranteed investment?	Yes
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

Potentially related plans

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
Employer identification number (EIN):	362406080
NAIC Classification:	813000
NAIC Description:	Religious, Grantmaking, Civic, Professional, and Similar Organizations